Registration for the September 4, 2024 (9:00-10:30am Pacific Time), virtual town hall meeting regarding the UW’s Diversity in Clinical Trials Initiative is now open. This event is intended to provide researchers and other interested parties with the opportunity to ask questions and provide feedback on the soon to be published draft diversity plan and associated guidance. The DCTI policy is now ready for review and public feedback.

The event will begin with a 30-minute overview presentation, followed by a 60-minute Q&A. Attendees are encouraged to submit in advance any questions they would like addressed using the Contact Us form on the UW DCTI website. For those unable to attend, a post-session recording will be available.

The Diversity in Clinical Trials Initiative (DCTI) is inclusive of Washington Legislature House Bill 1745 as well as the  guidance from the FDA regarding the equitable selection of clinical trial participants and development of a diversity plan. The Diversity in Clinical Trials Initiative aims to enhance representation of historically underrepresented communities among participants in clinical studies, ensuring that medical treatments and interventions are effectively studied across diverse populations, leading to more equitable healthcare outcomes for all individuals and better medicine. The University of Washington is taking this opportunity to review and revise our clinical trial policies with deeper and more comprehensive diversity criteria to usher in a new era of inclusive medical research.

Register here!